Summit Therapeutics Inc. (SMMT) operating KPIs
SMMTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$16.03−0.17 (-1.05%)
Close on Oct 30, 2026Market cap $12.79BP/E –Yield –
KPIs
Operating metrics that drive Summit Therapeutics's business
| Countries of operation | Q3 24 | Q2 24 | Q1 24 | Q3 23 | Q2 23 | Q1 23 | Q3 22 | Q2 22 | Q1 22 | Q3 21 | Q2 21 | Q1 21 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Countries of operation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 0.0% |
Counts and sizes Summit Therapeutics tags in the notes of its 10-K and 10-Q filings (XBRL), as of the end of each quarter. Breakdowns follow the company's own labels; at most 15 are shown per metric. A fuller KPI sheet built from earnings releases and presentations is on the way. See how companies compare on these metrics.